Ligand validation:3CL2

G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid

G39 is a Ligand Of Interest in 3CL2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CL2_G39_C_802	76%	21%	0.118	0.955	1.95	1.38	6	4	1	0	100%	1
3CL2_G39_H_808	75%	18%	0.127	0.959	2.04	1.51	6	6	0	0	100%	1
3CL2_G39_B_801	71%	18%	0.148	0.968	1.98	1.53	7	5	0	0	100%	1
3CL2_G39_D_803	70%	21%	0.14	0.958	1.99	1.32	5	3	0	0	100%	1
3CL2_G39_F_806	70%	16%	0.143	0.961	2.09	1.61	6	5	0	0	100%	1
3CL2_G39_G_807	69%	17%	0.138	0.954	1.97	1.68	5	6	0	0	100%	1
3CL2_G39_A_800	69%	19%	0.147	0.963	1.99	1.47	6	5	0	0	100%	1
3CL2_G39_E_805	67%	19%	0.149	0.957	2.14	1.34	6	3	0	0	100%	1
2HU4_G39_A_800	100%	7%	0.023	0.996	2.69	2.1	6	6	0	0	100%	1
4B7R_G39_D_801	95%	9%	0.062	0.966	1.92	2.46	4	2	0	0	100%	1
3CL0_G39_A_800	87%	53%	0.071	0.942	0.75	1.06	-	1	0	0	100%	1
5NZ4_G39_B_503	86%	52%	0.083	0.952	0.89	0.96	1	1	0	0	100%	1
5NZF_G39_A_503	84%	45%	0.089	0.95	1	1.12	2	2	0	0	100%	1
4K1J_G39_A_508	94%	4%	0.062	0.961	2.6	3.04	5	8	0	0	100%	1
6HEB_G39_A_522	94%	53%	0.07	0.969	0.73	1.06	1	1	0	0	100%	1
4MWQ_G39_A_513	94%	4%	0.062	0.96	3.28	2.34	6	8	0	0	100%	1
4HZZ_G39_A_509	93%	8%	0.065	0.96	2.61	2.03	6	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.